GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jiangsu Aoyang Health Industry Co 002172.SZ · CNY

Materials · Shenzhen · 🇨🇳 China

Compare

6.18

+9.96%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Jiangsu Aoyang Health Industry Co

Its shares trade on Shenzhen under the ticker 002172.SZ. It has been listed since 21 September 2007. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.81bn and net income of CN¥41.3m. At that date it held total assets of CN¥1.79bn and shareholders' equity of CN¥175.9m.

Jiangsu Aoyang Health Industry Co., Ltd. provides healthcare and medical services. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2007-09-21. The firm operates its businesses through two segments. The Chemical Fibers segment is engaged in the production and distribution of viscose staple fibers. The Health and Medical segment is engaged in the provision of medical service, medical distribution service and health management service. The firm distributes its products in both domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Materials
Industry
Chemicals
Listed since
21 Sept 2007
Employees
2,274
Website
ayjk.cn ↗

Leadership

Pay as last reported

  • Mr. Xueru ShenChairman of the BoardCN¥602,000
  • Ms. Jing LiVice Chairman of the Board, General Manager, since 2019CN¥451,800
  • Ms. Xia LiChief Financial Officer
  • Mr. Zhihao ZhuDeputy General Manager, DirectorCN¥421,800
  • Mr. Wei WangDeputy General ManagerCN¥401,700
  • Mr. Chao JiSecretary of the Board, Director, since 2019CN¥321,800
  • Mr. Kefeng LiDirector
  • Mr. Yibing YuanDirector, since 2018CN¥371,700
  • Mr. Heping ChenIndependent DirectorCN¥60,000
  • Mr. Xiaojun WuIndependent Director
  • Mr. Guohui XuIndependent DirectorCN¥60,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The company operates through two distinct business segments.
  • It produces and distributes viscose staple fibers.
  • It provides medical and health management services.

Weaknesses

  • The source description is explicitly treated as untrusted.
  • Financial data specifics are not provided in the text.
  • Operational details beyond segment names are missing.

Opportunities

  • The firm distributes products in overseas markets.
  • It offers medical distribution services to clients.
  • Health management services expand its service portfolio.

Threats

  • The provided source information is unreliable.
  • Competitor data is absent from the description.
  • Market conditions are not detailed in the text.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.